Nabriva Therapeutics plc
Q2 2019 vs. Q1 2022 13F Holders
Period
Q2 2019
Q1 2022
Num holders
50
1
Total reported value, excl. options
$71.4 M
$2.00 k
Total shares, excl. options
29,451,820
5,000
Compare Q1 2022 to
2022 Q2
2021 Q4
2021 Q3
2021 Q2
2021 Q1
2020 Q4
2020 Q3
2020 Q2
2020 Q1
2019 Q4
2019 Q3
2019 Q2
2019 Q1
2018 Q4
2018 Q3
2018 Q2
2018 Q1
2017 Q4
2017 Q3
2017 Q2
Manager
Q2 2019
Shares
Q1 2022
Shares
Diff
Chg %